A proof-of-concept analysis from the ongoing RESTORE clinical trial, conducted by researchers at the University of Colorado Anschutz Medical Campus, examined the impact of injectable semaglutide among participants aged 12 to 35 years with PCOS and obesity
Virta Health offers a medically supported, lifestyle-based approach to improving metabolic health for people seeking weight loss or diabetes management without relying on GLP-1 medication alone
Semaglutide, the active part, lasts longer than natural GLP-1
Stronger muscles support better posture, more controlled movement, and greater physical confidence
doi:10.1007/s00210-023-02452-2
With BPC-157, the benefits are unproven and the risks unknown a scenario that challenges the ethical boundaries of clinical practice